News

Cantor Fitzgerald is maintaining a bearish stance on equities, cautioning that the recent market rebound which has been driven largely by investor positioning—is likely behind us. The firm ...
Cantor Fitzgerald is set to launch a $3 billion ... This collaboration aims to mirror the investment approach pioneered by Michael Saylor's Strategy, which has seen significant success in the ...
Cantor Fitzgerald, the financial services firm formerly led by ... access Bitcoin’s price movements without investing in the currency directly, similar to Michael Saylor’s Strategy. It also plans to ...
Cantor Fitzgerald analyst Steve Seedhouse assumed coverage of ProQR Therapeutics (PRQR) with an Overweight rating and $8 price target ProQR is a leader in RNA editing and the initial biomarker ...
An affiliate of Cantor Fitzgerald LP is teaming up with stablecoin ... the latest company to emulate the business model of Michael Saylor’s Strategy. Twenty One said it expects to launch with ...
Bond brokerage Cantor Fitzgerald, stablecoin giant Tether and ... into a bitcoin volatility juggernaut by billionaire co-founder Michael Saylor. Thanks to clever financial engineering and leverage ...
On Tuesday, Cantor Fitzgerald analyst Sarah James reaffirmed an Overweight rating on CVS Health (NYSE:CVS) with a steady price target of $71.00. The rating aligns with the company’s strong ...
On Monday, Cantor Fitzgerald reaffirmed its Overweight rating on Travere Therapeutics (NASDAQ:TVTX), which has seen its stock surge 21.31% in the past week and an impressive 248.48% over the last ...
Fintel reports that on May 5, 2025, Cantor Fitzgerald downgraded their outlook for Onto Innovation (BMV:ONTO) from Overweight to Neutral. There are 501 funds or institutions reporting positions in ...
Cantor Fitzgerald has a “Overweight” rating and a $355.00 price objective on the stock. The consensus estimate for Tesla’s current full-year earnings is $2.56 per share. Get Tesla alerts: ...